ArticleOncotarget2015

Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model.

Hiroyasu Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.